Dr. Dipanjan Banerjee, MD

Dr. Banerjee practices at Surgical Specialties ASC in Hon, Hawaii.

Dr. Banerjee's NPI, 1295787299, was assigned on May 17, 2006. Dr. Banerjee graduated from University of Missouri School of Medicine in 2002. Dr. Banerjee holds Wisconsin license 101573-875.

Dr. Banerjee's primary practice is Surgical Specialties ASC, at 1329 Lusitana St, Suite 401, Hon, HI 96813. The practice phone is (808) 777-4172.

Dr. Banerjee's primary practice is Surgical Specialties ASC in Hon, Hawaii. Dr. Banerjee is also affiliated with The Queen's Medical Center. The medical group on file is The Queen's Medical Center. Dmand AI also links Dr. Banerjee to 4 more hospitals, 4 group practices and clinics, 4 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Banerjee practices, 11 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Banerjee's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Banerjee is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Banerjee's licenses on file in 4 states: Wisconsin, Oregon, Hawaii and California.

Dmand AI lists cardiomyopathy and heart failure among the conditions Dr. Banerjee treats.

CMS data shows 362 Medicare services from Dr. Banerjee across 8 procedure codes in 2024, for 143 Medicare patients. Medicare paid $39,192 for them.

CMS counts 143 Medicare patients who saw Dr. Banerjee in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Banerjee's median patient age at 73, with 47% women.

In 2024, Dr. Banerjee wrote 845 Medicare Part D claims for 208 patients. 73% of them were for generic drugs. CMS names the drug for 617 of them, across 16 drugs with 11 or more claims each, at $619,135 in total drug cost. In 2023, CMS named 1,881 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Banerjee for performance year 2024, reported through an alternative payment model (APM). Dr. Banerjee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Banerjee as offering telehealth.

Dmand AI links 163 papers to Dr. Banerjee, published from 2007 to 2025. 2023 was the busiest year, with 14. The most frequent topics are Heart Failure, Heart-Assist Devices and Heart Ventricles. Dr. Banerjee has published most often in Phys Rev Lett. Dr. Banerjee's most frequent co-authors are Richard Ha, DO, William Hiesinger, MD and Archana Sinha, MD.

CMS Open Payments shows 547 general payments to Dr. Banerjee from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Bristol-Myers Squibb Company paid the most, $226,538.

Dmand AI lists 14 awards for Dr. Banerjee, most recently CMS Stage 1 EHR in 2013.

Dr. Banerjee graduated from University of Missouri School of Medicine in 2002.

Dr. Banerjee is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.